Literature DB >> 9052515

Transforming growth factor-alpha (TGF-alpha) levels in human proximal gastrointestinal epithelium. Effect of mucosal injury and acid inhibition.

J M Scheiman1, K S Meise, J K Greenson, R J Coffey.   

Abstract

TGF-alpha inhibits gastric acid secretion and may play an important role in epithelial repair. We quantitated regional levels of TGF-alpha in the human proximal gastrointestinal tract and determined whether they are affected by acid suppression or aspirin-induced injury. Ten healthy volunteers were studied. After baseline endoscopy with biopsy, five randomly received no treatment, aspirin, omeprazole, or cimetidine for one week. Endoscopy was repeated and prior unhealed biopsy sites quantitated. TGF-alpha levels were measured by RIA. Five additional subjects then completed an extended protocol of three weeks duration. All subjects were free of H. pylori infection. TGF-alpha levels in the antrum, 34.76 +/- 5.54 pg TGF-alpha/micrograms DNA were threefold higher than in the gastric body and duodenum (11.03 +/- 2.60 and 10.41 +/- 1.64 respectively, P < 0.01). The number of unhealed sites in the aspirin group was significantly greater than in the control or acid inhibition groups; however, TGF-alpha levels were not different from-the surrounding mucosa. TGF-alpha increased in the controls after biopsy; the increase was significant in the body at week 2 only. Aspirin significantly increased TGF-alpha levels in the gastric body and duodenum after one week. The rise in antral TGF-alpha appeared delayed and blunted by the aspirin treatment compared to control. There was no relationship between the number of visible biopsy sites, degree of aspirin-induced injury, and the TGF-alpha level. Acid suppression was associated with a significant increase in TGF-alpha in the gastric body and antrum at one week. Immunochemical staining did not demonstrate differences in proliferation in any treatment group compared to controls. TGF-alpha levels vary by location in the proximal gastrointestinal tract, with significantly greater levels in the antrum. After biopsy, TGF-alpha levels increase; short-term aspirin and acid inhibitors modulate this effect. Aspirin significantly impaired the healing of endoscopic biopsies in the antrum; however, this was not associated with changes in TGF-alpha levels. TGF-alpha levels did not change in response to acid secretory state. Further studies of mucosal levels of TGF-alpha in response to aspirin-induced injury in humans appear warranted.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9052515     DOI: 10.1023/a:1018865918932

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  31 in total

1.  Immunoreactivity of transforming growth factor alpha in the normal adult gastrointestinal tract.

Authors:  D M Thomas; M M Nasim; W J Gullick; M R Alison
Journal:  Gut       Date:  1992-05       Impact factor: 23.059

2.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

3.  Inhibition of parietal cell H+ secretion by transforming growth factor alpha: a possible autocrine regulatory mechanism.

Authors:  J J Lewis; J R Goldenring; I M Modlin; R J Coffey
Journal:  Surgery       Date:  1990-08       Impact factor: 3.982

Review 4.  Epithelial restitution in the gastrointestinal tract.

Authors:  E R Lacy
Journal:  J Clin Gastroenterol       Date:  1988       Impact factor: 3.062

5.  Epidermal growth factor is digested to smaller, less active forms in acidic gastric juice.

Authors:  R J Playford; T Marchbank; D P Calnan; J Calam; P Royston; J J Batten; H F Hansen
Journal:  Gastroenterology       Date:  1995-01       Impact factor: 22.682

6.  TGF-alpha is a potent mitogen for primary cultures of guinea pig gastric mucous epithelial cells.

Authors:  M J Rutten; P J Dempsey; T E Solomon; R J Coffey
Journal:  Am J Physiol       Date:  1993-08

7.  Regional distribution of transforming growth factor-alpha and epidermal growth factor in normal and portal hypertensive gastric mucosa in humans.

Authors:  M Romano; K S Meise; R Suozzo; G Sessa; M Persico; R J Coffey
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

Review 8.  Epidermal growth factor in protection, repair, and healing of gastroduodenal mucosa.

Authors:  J W Konturek; T Brzozowski; S J Konturek
Journal:  J Clin Gastroenterol       Date:  1991       Impact factor: 3.062

9.  Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections.

Authors:  G Cattoretti; M H Becker; G Key; M Duchrow; C Schlüter; J Galle; J Gerdes
Journal:  J Pathol       Date:  1992-12       Impact factor: 7.996

10.  Time course of mucosal cell proliferation following acute aspirin injury in rat stomach.

Authors:  G V Ohning; P H Guth
Journal:  Dig Dis Sci       Date:  1995-06       Impact factor: 3.199

View more
  2 in total

1.  Novel mechanistic insights into ectodomain shedding of EGFR Ligands Amphiregulin and TGF-α: impact on gastrointestinal cancers driven by secondary bile acids.

Authors:  Nagaraj S Nagathihalli; Yugandhar Beesetty; Wooin Lee; M Kay Washington; Xi Chen; A Craig Lockhart; Nipun B Merchant
Journal:  Cancer Res       Date:  2014-02-11       Impact factor: 12.701

2.  Comparison of the antisecretory and antiulcer activity of epidermal growth factor, urogastrone and transforming growth factor alpha and its derivative in rodents in vivo.

Authors:  S M A Bastaki; S I Chandranath; J Singh
Journal:  Mol Cell Biochem       Date:  2002-07       Impact factor: 3.396

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.